
Lack of a Dose‐response Relationship for Carcinogenicity in the Rat Liver with Low Doses of 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline or N‐Nitrosodiethylamine
Author(s) -
Fukushima Shoji,
Wanibuchi Hideki,
Morimura Keiichirou,
Wei Min,
Nakae Dai,
Konishi Yoichi,
Tsuda Hiroyuki,
Uehara Nobuaki,
Imaida Katsumi,
Shirai Tomoyuki,
Tatematsu Masae,
Tsukamoto Tetsuya,
Hirose Masao,
Furukawa Fumio,
Wakabayashi Keiji,
Totsuka Yukari
Publication year - 2002
Publication title -
japanese journal of cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 0910-5050
DOI - 10.1111/j.1349-7006.2002.tb01208.x
Subject(s) - carcinogen , quinoxaline , glutathione , liver cancer , chemistry , cancer , nitrosamine , dna adduct , genotoxicity , cancer research , pharmacology , biochemistry , toxicology , biology , medicine , genetics , toxicity , enzyme , organic chemistry
For a long period, it has been generally considered that carcinogens, particularly genotoxic ones, have no threshold in exerting their potential for cancer induction. However, the non‐threshold theory can be challenged with regard to assessment of cancer risk to humans. Here we show that a food‐derived, genotoxic hepatocarcinogen, 2‐amino‐3,8‐dimethylimidazo[4,5‐ f ]quinoxaline, forms DNA adducts at low doses, but does not induce glutathione S‐transferase placental form (GST‐P)‐positive foci (considered to be preneoplastic lesions) or 8‐hydroxy‐2′‐deoxyguanosine in rat liver. Moreover a N ‐nitroso compound, N ‐nitrosodiethylamine, at low doses was also found not to induce GST‐P‐positive foci in rat liver. These results imply that there is a no‐observed effect level for hepatocarcinogenesis by these genotoxic carcinogens.